We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

125 hedge funds and large institutions have $210M invested in Arena Pharmaceuticals Inc in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 44 increasing their positions, 35 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 7

47% more call options, than puts

Call options by funds: $1.37M | Put options by funds: $931K

26% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 35

5% more funds holding

Funds holding: 119 → 125 (+6)

3% more capital invested

Capital invested by funds: $203M → $210M (+$6.69M)

Holders
125
Holders Change
+6
Holders Change %
+5.04%
% of All Funds
3.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
44
Reduced
35
Closed
7
Calls
$1.37M
Puts
$931K
Net Calls
+$436K
Net Calls Change
-$161K

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$2.21M
2
BFA
BlackRock Fund Advisors
California
+$766K
3
TC
TFS Capital
Pennsylvania
+$642K
4
Millennium Management
Millennium Management
New York
+$581K
5
State Street
State Street
Massachusetts
+$477K

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.92M
2
SAM
Senzar Asset Management
New York
-$389K
3
Deutsche Bank
Deutsche Bank
Germany
-$247K
4
VKH
Virtu KCG Holdings
New York
-$233K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$178K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
51
Citigroup
New York
$160K +$47.6K +2,873 +45%
SG Americas Securities
52
SG Americas Securities
New York
$123K +$38.4K +2,318 +49%
UBS Group
53
UBS Group
Switzerland
$116K +$12.1K +730 +12%
AG
54
Aperio Group
California
$104K -$30.7K -1,854 -24%
Invesco
55
Invesco
Georgia
$99K +$365 +22 +0.4%
Legal & General Group
56
Legal & General Group
United Kingdom
$92K – – –
T. Rowe Price Associates
57
T. Rowe Price Associates
Maryland
$92K – – –
HK
58
Horizon Kinetics
New York
$79K – – –
Creative Planning
59
Creative Planning
Kansas
$78K +$1.99K +120 +3%
LWM
60
Lyons Wealth Management
Florida
$74K – – –
Principal Financial Group
61
Principal Financial Group
Iowa
$74K – – –
ASN
62
Advisory Services Network
Georgia
$64K – – –
JCM
63
Jacobi Capital Management
Pennsylvania
$64K – – –
Two Sigma Advisers
64
Two Sigma Advisers
New York
$60K +$166 +10 +0.3%
Barclays
65
Barclays
United Kingdom
$58K +$50.5K +3,042 +1,521%
HSBC Holdings
66
HSBC Holdings
United Kingdom
$55K +$49.8K +3,000 +3,371%
Commonwealth Equity Services
67
Commonwealth Equity Services
Massachusetts
$52K -$4.15K -250 -8%
CA
68
Commerzbank Aktiengesellschaft
Germany
$50K -$2.84K -171 -6%
WPC
69
Waters Parkerson & Co
Louisiana
$50K +$47.4K +2,858 New
QIM
70
Quantitative Investment Management
Virginia
$49K -$68.7K -4,140 -60%
Prudential Financial
71
Prudential Financial
New Jersey
$47K +$2.42K +146 +6%
PCM
72
Prelude Capital Management
New York
$46K -$32.8K -1,980 -43%
AB
73
Amalgamated Bank
New York
$46K +$216 +13 +0.5%
RJFSA
74
Raymond James Financial Services Advisors
Florida
$46K +$3.81K +230 +10%
AIM
75
Alambic Investment Management
California
$46K +$24.7K +1,490 +130%
1 2
3
4 5

ARNA Hedge Fund Activity: Q3 2016 in Review

125 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q3 2016, worth a combined $210M — up 3.3% from $203M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ARNA positions and 7 closed out — a net gain of 7 holders — while 44 added to existing stakes and 35 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $2.21M. The largest seller was Wellington Management Group, cutting an estimated $1.92M.

  • 125 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q3 2016, up from 119 in Q2 2016.
  • Funds reported $210M of Arena Pharmaceuticals Inc stock for Q3 2016, up 3.3% quarter-over-quarter.
  • 14 funds opened new Arena Pharmaceuticals Inc positions in Q3 2016 and 7 closed out, a net change of +7 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q3 2016 was Renaissance Technologies, an estimated $2.21M added.
  • The largest Arena Pharmaceuticals Inc seller in Q3 2016 was Wellington Management Group, an estimated $1.92M sold.

Based on aggregated 13F filings for Q3 2016.